BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35742918)

  • 21. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
    Chen Y; Li ZY; Zhou GQ; Sun Y
    Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
    Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
    Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
    Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
    Eder T; Hess AK; Konschak R; Stromberger C; Jöhrens K; Fleischer V; Hummel M; Balermpas P; von der Grün J; Linge A; Lohaus F; Krause M; Baumann M; Stuschke M; Zips D; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Budach V; Tinhofer I;
    Eur J Cancer; 2019 Jul; 116():67-76. PubMed ID: 31173964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
    Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
    Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
    Yang R; Klimentová J; Göckel-Krzikalla E; Ly R; Gmelin N; Hotz-Wagenblatt A; Řehulková H; Stulík J; Rösl F; Niebler M
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30918060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
    García-Escudero R; Segrelles C; Dueñas M; Pombo M; Ballestín C; Alonso-Riaño M; Nenclares P; Álvarez-Rodríguez R; Sánchez-Aniceto G; Ruíz-Alonso A; López-Cedrún JL; Paramio JM; Lorz C
    Oral Oncol; 2018 Apr; 79():55-63. PubMed ID: 29598951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
    Wittekindt C; Wagner S; Mayer CS; Klußmann JP
    Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
    Wang L; Jia Y; Jiang Z; Gao W; Wang B
    Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
    Hu C; Fan J; He G; Dong C; Zhou S; Zheng Y
    PLoS One; 2022; 17(6):e0269166. PubMed ID: 35653344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma.
    Yang J; Jiang Q; Liu L; Peng H; Wang Y; Li S; Tang Y; Yu J; Gan R; Liu Z
    Aging (Albany NY); 2020 Nov; 12(24):25778-25804. PubMed ID: 33232279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma.
    Starzer AM; Heller G; Tomasich E; Melchardt T; Feldmann K; Hatziioannou T; Traint S; Minichsdorfer C; Schwarz-Nemec U; Nackenhorst M; Müllauer L; Preusser M; Berghoff AS; Fuereder T
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35338086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.
    Ma C; Li H; Li X; Lu S; He J
    Biomark Med; 2019 Nov; 13(16):1399-1415. PubMed ID: 31596126
    [No Abstract]   [Full Text] [Related]  

  • 40. Profiles of immune cell infiltration in head and neck squamous carcinoma.
    Liang B; Tao Y; Wang T
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.